v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 19,491 $ 11,948 $ 54,943 $ 31,126
General and administrative 9,282 7,571 28,650 25,709
Total operating expenses 28,773 19,519 83,593 56,835
Loss from operations (28,773) (19,519) (83,593) (56,835)
Other (income), net        
Interest income (1,759) (1,526) (4,998) (5,060)
Other expense (income), net 32 47 (941) (300)
Total other (income), net (1,727) (1,479) (5,939) (5,360)
Loss before income taxes (27,046) (18,040) (77,654) (51,475)
Income tax benefit (1,221) 0 (1,302) 0
Net loss (25,825) (18,040) (76,352) (51,475)
Accretion of redeemable noncontrolling interest to redemption value 0 (2,828) 0 (2,828)
Adjustment of redeemable noncontrolling interest 0 831 0 831
Net loss attributable to Class A Ordinary Shareholders of Zura $ (25,825) $ (20,037) $ (76,352) $ (53,472)
Net loss per share, basic (in dollars per share) $ (0.20) $ (0.21) $ (0.62) $ (0.57)
Net loss per share, diluted (in dollars per share) $ (0.20) $ (0.21) $ (0.62) $ (0.57)
Weighted-average shares outstanding, basic (in shares) 127,712,533 94,564,632 122,303,170 93,941,675
Weighted-average shares outstanding, diluted (in shares) 127,712,533 94,564,632 122,303,170 93,941,675